PLC Announces Approval to Distribute RenalGuard® in Brazil
“Approval to sell RenalGuard in Brazil is yet another significant development for PLC,” said Mark R. Tauscher, President and Chief Executive Officer of PLC Systems.
Articles by admin
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
OncoSec Closes $7.75 Million Public Offering
OncoSec intends to use proceeds from the offering for general corporate purposes, including clinical trial expenses and research and development expenses.
CS-131: One of the Most Significant Advancements in Brachytherapy
Brachytherapy, a form of radiation therapy where radioactive seeds – or isotopes – are placed near or inside the tumor to emit radiation, is one of the most intriguing both in the medical and investor community.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
The Magazine For Decision Makers in a Global Industry Launches in NYC
New Pharma Magazine celebrated the launch of the first edition in New York City last week by partnering with the Drug Chemical and Associated Technologies Association.
Brachytherapy: Why Chemotherapy May Soon Be a Thing of the Past
Brachytherapy is considered to be one of the oldest techniques for the treatment of various cancers, particularly for prostate cancer.
May 2 – 3 2012, NYBA 21st Annual Meeting
New York Biotechnology Association (NYBA) will develop its Emerging Companies Showcase through a partnership with OneMedPlace.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.